Know Cancer

or
forgot password
  • cancer clinical trials in new britain, CT

  • Dasatinib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Cognition in the Study of Tamoxifen and Raloxifene
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Cognition, Aging
    Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

    New Britain, Connecticut 06052
    Rheumatoid Arthritis
    Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Endometrial Cancer
    Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes
    Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Study of Degarelix in Patients With Prostate Cancer
    Grove Hill Medical Center
    New Britain, Connecticut
    Prostate Cancer
    Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer
    Grove Hill Medical Center
    New Britain, Connecticut
    Bladder Neoplasm, Intravesical Drug Administration, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma, Carcinoma in Situ, Mycobacterium
    AMG 386 in Treating Patients With Persistent or Recurrent Endometrial Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Endometrial Cancer
    Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Recurrent Uterine Sarcoma, Uterine Leiomyosarcoma
    A Study of RO5185426 in Patients With Metastatic Melanoma

    New Britain, Connecticut 06052
    Malignant Melanoma
    Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer
    The Hospital of Central Connecticut
    New Britain, Connecticut 06050
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Small Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    Brivanib in Treating Patients With Persistent or Recurrent Cervical Cancer
    George Bray Cancer Center at the Hospital of Central Connecticut - New Britain Campus
    New Britain, Connecticut 06050
    Cervical Cancer